- Home
- TNGX vs SPFI Comparison
TNGX vs SPFI Comparison
Compare TNGX & SPFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- SPFI
- Stock Information
- Founded
- TNGX 2014
- SPFI 1941
- Country
- TNGX United States
- SPFI United States
- Employees
- TNGX N/A
- SPFI N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- SPFI Major Banks
- Sector
- TNGX Health Care
- SPFI Finance
- Exchange
- TNGX Nasdaq
- SPFI Nasdaq
- Market Cap
- TNGX 723.2M
- SPFI 662.8M
- IPO Year
- TNGX N/A
- SPFI 2019
- Fundamental
- Price
- TNGX $6.63
- SPFI $39.84
- Analyst Decision
- TNGX Strong Buy
- SPFI Buy
- Analyst Count
- TNGX 6
- SPFI 3
- Target Price
- TNGX $10.00
- SPFI $41.67
- AVG Volume (30 Days)
- TNGX 1.3M
- SPFI 43.4K
- Earning Date
- TNGX 11-05-2025
- SPFI 10-22-2025
- Dividend Yield
- TNGX N/A
- SPFI 1.49%
- EPS Growth
- TNGX N/A
- SPFI 19.09
- EPS
- TNGX N/A
- SPFI 3.20
- Revenue
- TNGX $24,296,000.00
- SPFI $199,001,000.00
- Revenue This Year
- TNGX $6.56
- SPFI $13.41
- Revenue Next Year
- TNGX N/A
- SPFI $6.10
- P/E Ratio
- TNGX N/A
- SPFI $12.63
- Revenue Growth
- TNGX N/A
- SPFI 7.49
- 52 Week Low
- TNGX $1.03
- SPFI $30.01
- 52 Week High
- TNGX $10.85
- SPFI $42.38
- Technical
- Relative Strength Index (RSI)
- TNGX 49.24
- SPFI 50.44
- Support Level
- TNGX $6.25
- SPFI $39.62
- Resistance Level
- TNGX $7.40
- SPFI $40.93
- Average True Range (ATR)
- TNGX 0.40
- SPFI 1.01
- MACD
- TNGX -0.05
- SPFI -0.16
- Stochastic Oscillator
- TNGX 33.04
- SPFI 12.02
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About SPFI South Plains Financial Inc.
South Plains Financial Inc operates as a bank holding company. The company provides a wide range of commercial and consumer financial services to small and medium-sized businesses and individuals. The principal business activities include commercial and retail banking, along with insurance, investment, trust, and mortgage services. The company has one reportable segment: banking.